Suppr超能文献

次氮基三乙酸铁对L5178Y小鼠淋巴瘤细胞的细胞毒性和致突变作用。

Cytotoxic and mutagenic effects of ferric nitrilotriacetate on L5178Y mouse lymphoma cells.

作者信息

Toyokuni S, Sagripanti J L, Hitchins V M

机构信息

U.S. Food and Drug Administration, Rockville, MD 20857.

出版信息

Cancer Lett. 1995 Jan 27;88(2):157-62. doi: 10.1016/0304-3835(94)03641-u.

Abstract

An iron chelate, ferric nitrilotriacetate (Fe-NTA), induces renal proximal tubular necrosis that leads to a high incidence of renal adenocarcinoma in rodents. Others have shown that Fe-NTA induces modified DNA base products both in vitro and in vivo. However, Fe-NTA is negative in the Ames Salmonella test with or without S9 activation. The goal of this project was to determine if Fe-NTA is cytotoxic and mutagenic using the L5178Y (TK +/-) mouse lymphoma assay. Our experiments showed a relationship between the concentration of Fe-NTA (0 to 1 mM) and the decrease in relative survival. An exposure-dependent increase in the number of mutations was observed with increasing concentrations of Fe-NTA. At 14% relative survival, there was about a 4-fold increase in mutations (trifluorothymidine resistance) over unexposed, control cells. Ferric nitrate or nitrilotriacetic acid alone induced a relatively low 1.5- or 1.1-fold increase in mutation, respectively. Our results establish that Fe-NTA is mutagenic in the L5178Y mouse lymphoma assay system.

摘要

一种铁螯合物,次氮基三乙酸铁(Fe-NTA),可诱导啮齿动物肾近端小管坏死,进而导致肾腺癌的高发病率。其他人已经表明,Fe-NTA在体外和体内均能诱导修饰的DNA碱基产物。然而,无论有无S9激活,Fe-NTA在艾姆斯沙门氏菌试验中均呈阴性。本项目的目标是使用L5178Y(TK+/-)小鼠淋巴瘤试验来确定Fe-NTA是否具有细胞毒性和致突变性。我们的实验表明,Fe-NTA的浓度(0至1 mM)与相对存活率的降低之间存在关联。随着Fe-NTA浓度的增加,观察到突变数量呈暴露依赖性增加。在相对存活率为14%时,与未暴露的对照细胞相比,突变(三氟胸苷抗性)增加了约4倍。单独的硝酸铁或次氮基三乙酸分别诱导相对较低的1.5倍或1.1倍的突变增加。我们的结果证实,Fe-NTA在L5178Y小鼠淋巴瘤试验系统中具有致突变性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验